Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A phase 2, randomized, double blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients (SAV005-02)
Danov, Zoran
(PI)
Anstead, Michael
(CoI)
Kanga, Jamshed
(CoI)
Pediatrics
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
3/13/13
→
3/31/15
Funding
Savara Incorporated:
$6,598.00
View all
View less